2004
DOI: 10.1161/01.cir.0000116764.53225.a9
|View full text |Cite
|
Sign up to set email alerts
|

Renal Insufficiency and Heart Failure

Abstract: Background-The prevalence, prognostic import, and impact of renal insufficiency on the benefits of ACE inhibitors and ␤-blockers in community-dwelling patients with heart failure are uncertain. Methods and Results-We analyzed data from a prospective cohort of 754 patients with heart failure who had ejection fraction, serum creatinine, and weight measured at baseline. Median age was 69 years, and 43% had an ejection fraction Ն35%. By the Cockcroft-Gault equation, 118 patients (16%) had creatinine clearances Յ30… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

13
207
1
8

Year Published

2006
2006
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 635 publications
(229 citation statements)
references
References 40 publications
13
207
1
8
Order By: Relevance
“…they tended to be slightly younger, were less likely to be women, had a higher prevalence of previous HF and a lower LVEF, compared to the patients enrolled in some [10][11][12] but not other [13][14][15][16][17] previous larger studies, several of which included only patients ≥ 65 years. The prevalence of concomitant diseases and, namely, of previous chronic renal failure as well as the s-Cr, BUN and eGFR values on admission of our patients were similar to those in previous studies [5,[9][10][11][12][13][14][15][16][17].…”
Section: Patient Characteristicssupporting
confidence: 88%
See 1 more Smart Citation
“…they tended to be slightly younger, were less likely to be women, had a higher prevalence of previous HF and a lower LVEF, compared to the patients enrolled in some [10][11][12] but not other [13][14][15][16][17] previous larger studies, several of which included only patients ≥ 65 years. The prevalence of concomitant diseases and, namely, of previous chronic renal failure as well as the s-Cr, BUN and eGFR values on admission of our patients were similar to those in previous studies [5,[9][10][11][12][13][14][15][16][17].…”
Section: Patient Characteristicssupporting
confidence: 88%
“…Renal dysfunction is a frequent finding in patients with heart failure (HF) and is a powerful independent prognostic factor for adverse outcomes [1][2][3][4][5][6][7][8]. Its prevalence increases in patients with more severe HF.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, the increased risk of bleeding may be due to platelet dysfunction, prolonged bleeding time, and small vessel disease associated with CKD 27, 28. Overall, CKD may be associated with adverse outcomes in HF, as it is a marker of more severe HF, greater symptom burden, and/or coexistent disease 1, 2, 29. The poorer survival in patients with CKD and HF may also reflect the reduced likelihood of being prescribed evidence‐based therapies,29, 30 as CKD is often viewed as a contraindication to some therapies,2, 29 including thromboprophylactic therapies 31.…”
Section: Discussionmentioning
confidence: 99%
“…Heart failure (HF) and chronic kidney disease (CKD) often coexist 1, 2, 3. Among HF patients with concomitant CKD, mortality and morbidity are high 4, 5.…”
Section: Introductionmentioning
confidence: 99%
“…Previous population‐based studies support our findings. In a study of 754 heart failure patients, survival was significantly tied to renal insufficiency with increased mortality associated with worsening renal dysfunction ( P  = 0.002) 16. Additionally, reduced GFR was associated with an increased risk of cardiovascular death and heart failure hospitalizations in 2680 North American patients with systolic and DD 17.…”
Section: Discussionmentioning
confidence: 99%